An 80-year-old male patient presented to the Emergency Department with abdominal pain, severe diaphoresis, diarrhoea and vomiting. Symptoms were occurring intermittently over the last year. Prior to admission, these symptoms worsened with a near syncopal episode. There was a background of vascular risk factors (triple vessel coronary bypass grafting, type 2 diabetes, hypertension, paroxysmal atrial fibrillation) and also Barrett's oesophagus. Examination findings included a systolic murmur and a soft abdomen, with pain on deep palpation of the right iliac fossa.
The next morning, abdominal pain and diarrhoea were already resolving, with unremarkable abdominal X-ray and faecal studies. Blood tests showed a worsening microcytic anaemia. On the background of Barrett's oesophagus, this raised suspicion of co-morbid gastrointestinal cancer, therefore, an urgent oesophago-gastro-duodenoscopy (OGD) was organised.
OGD showed stable appearances. The patient's symptoms resolved spontaneously and he was discharged with an outpatient abdominal CT scan arranged. This CT scan revealed a 3 × 2 cm ileal mesenteric mass, highly suggestive of small bowel carcinoid tumour (see Figure 1) . One area of local mesenteric adenopathy was detected, but no hepatic disease. Seventy-two hour urinary 5-hydroxyindoleacetic acid (5-HIAA) was not raised.
Multi-disciplinary team planning supported open small bowel resection. A right transverse incision revealed three loops of small bowel tethered to the mass by a scirrhous reaction. The lesion was excised 'en-bloc'. Intra-operatively, there was wide fluctuation in blood pressure associated with tumour manipulation, with systolic pressures ranging from 110 to 180. The patient had an uneventful postoperative recovery. Pathology revealed well differentiated endocrine carcinoma with complete excision surgical margins; classified as grade G1 with subserosal, vascular and perineural invasion, staged at pT3, N1, Mx.
Discussion
Carcinoid tumours are rare, slow-growing, neuroendocrine tumours. They can be classified into tumours of the foregut (bronchus, stomach, proximal duodenum, pancreas), midgut (distal duodenum, jejunum, ileum, right colon) and hindgut (distal large bowel and rectum). They rarely occur in other organs such as ovary, kidney and prostate [1] [2] [3] .
Small bowel tumours are uncommon (less than 0.1 per 100,000 globally) but carcinoid tumours are attributed to 35-42% of these [4, 5] . Ileal and jejunal tumours are multicentric from 26 to 30% of cases [6] . Small bowel carcinoids may be detected late from local effects of the tumour itself: obstruction (from luminal strictures), bleeding, ischaemic pain, and can also present via manifestation of carcinoid syndrome [7] .
Carcinoid syndrome relates to tumour release of substances such as serotonin or kallikrein causing symptoms, classically flushing, diarrhoea, bronchoconstriction and murmurs from cardiac valvular lesions [8, 9] . These substances undergo hepatic metabolisation, so carcinoid syndrome occurs with gastrointestinal tumours with hepatic metastasis. This can occur from 20 to 30% of mid-gut carcinoids [10, 11] . Local release of these substances can cause mesenteric fibrosis and desmoplasia seen as soft-tissue stranding on CT images (see Figure 1) [7] . Urinary 5-HIAA (a serotonin metabolite) may not always be raised, and serum chromogranin A (a neurosecretory protein) is a sensitive, but less specific test [12] .
Further evidence of carcinoid syndrome in this case was the labile blood pressure during surgery associated with tumour manipulation. Surgery and anaesthesia can trigger carcinoid crises that can cause hypo-or hypertension, bronchoconstriction and cardiac arrhythmias [8, 13] .
This case is interesting as the patient had good clinical symptoms for carcinoid syndrome, yet did not have CT evidence of hepatic metastasis. This has been reported in a limited case series [14] . One explanation is that the tumour had caused local invasion of the retroperitoneal circulation, thereby bypassing the portal vein circulation and allowing the tumour-produced hormones to have a clinical effect [15] . Another possibility is that the liver may breakdown serotonin via monoamine oxidase, but other substances (kallikrein, histamine, tachikinins) that may not be metabolised could still produce clinical symptoms [14, 16] .
Key points
• Carcinoid tumours are rare, slow growing neuroendocrine tumours that typically arise from the gastrointestinal tract and lung.
• Surgical resection can be complicated by blood pressure changes associated with tumour manipulation.
• Carcinoid syndrome can rarely occur in the absence of hepatic metastasis.
